GiXo (9219) · InitiativeRestated
Allocation of Listing-Related Funds to R&D and Human Resources Investment
First written in FY2022-Q3. 1 of 2 entries say "Restated". Latest entry: FY2022.
2entries
1years
0from disclosures
How it moved
Same theme, other companies
Use of Public Offering Capital Increase Proceeds for Investment in Talent and R&DA theme 6 companies write about · 0 as a headwind · 6 as a tailwind
2 other companies' latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- FY2022RestatedAnnual report
「The Company will make effective investments of retained funds in personnel recruitment and development, R&D investment, and other areas that will serve as sources of future growth.」
The Company has reaffirmed its policy of using retained funds for personnel and R&D investment to support growth. - FY2022-Q3First statedAnnual report
「(9) Use of funds Planned allocation to R&D and personnel investment」
The Company states that funds raised through the third-party allotment associated with the listing are scheduled to be allocated to R&D and personnel investment. The payment date for the third-party allotment was 26 April 2022, and the total allotment price was ¥86.528 million.